You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity without severe side effect

Article Text

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Immune-Stimulants and Immune Modulators
1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity without severe side effect

https://doi.org/10.1136/jitc-2023-SITC2023.1147-E

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.